脂肪原/吡啶霉素/BVT-0455-M001/1 mg
商品编号:
BVT-0455-M001
品牌:
Adipogen Inc
市场价:
¥5800.00
美元价:
3480.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | AntibioticU24544;Erizomycin;NSC246134 |
ProductType | Chemical |
Properties | |
Formula | C27H32N4O8 |
MW | 540.6 |
CAS | 18791-21-4 |
Source/HostChemicals | IsolatedfromStreptomycessp. |
PurityChemicals | ≥98%(1H-NMR,HPLC) |
Appearance | Off-whitesolid. |
Solubility | SolubleinDMSO,methanol,water,dichloromethaneoracetone. |
Identity | Determinedby1H-NMRandMS. |
Declaration | ManufacturedbyBioViotica. |
InChiKey | WHIKSLGSXKIHCA-IGCCMALHSA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | +4°C |
HandlingAdvice | Protectfromlightwheninsolution. |
Use/StABIlity | Stableforatleast1yearafterreceiptwhenstoredat+4°C. |
Documents | |
MSDS | DownloadPDF |
ProductSpecificationSheet | |
Datasheet | DownloadPDF |
- Cyclodepsipeptideantibiotic.Unusual12-memberedmacrocyclicdepsipeptidecomprisesthreeuniquesubunitsincorporatingtwosubstitutedpyridines.
- Potentantitubercularagent.
- InhibitorofNADH-dependentenoyl(Acyl-Carrier-Protein)reductaseInhA,preventingmycolicacidsynthesisinM.tuberculosis.
- Showntobeactiveagainstisoniazid-resistantmycobacteria.
ProductReferences
- Anewantibiotic,pyridomycin:K.Maeda,etal.;J.Antibiot.(Tokyo)6,140(1953)
- Structureofpyridomycin:G.Koyama,etal.;TetrahedronLett.37,3587(1967)
- Chemistryofpyridomycin:H.Ogawara,etal.;Chem.Pharm.Bull.16,679(1968)
- Syntheticstudiesofpyridomycin.V.Totalsynthesisofpyridomycin:M.Kinoshita,etal.;TetrahedronLett.30,7419(1989)
- IdentificationandcharacterizationofthepyridomycinbiosyntheticgeneclusterofstreptomycespyridomyceticusNRRLB-2517:T.Huang,etal.;J.Biol.Chem.286,20648(2011)
- Towardsanewtuberculosisdrug:pyridomycin-nature"sisoniazid:R.C.Hartkoorn,etal.;EMBOMol.Medicine4,1032(2012)
- PyridomycinbridgestheNADH-andsubstrate-bindingpocketsoftheenoylreductaseInhA:R.C.Hartkoorn,etal.;Nat.Chem.Biol.10,96(2014)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们